Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
10.1186/s12263-022-00713-y Genes Nutr
In general, GLP-1 coverage for obesity treatment has been more variable compared to that of diabetes management because obesity has historically not been recognized as a legitimate metabolic disease
Current research has not identified a specific membrane receptor exclusively responsible for BPC-157's effects, suggesting the peptide may interact with various signaling systems or function through novel mechanisms not yet fully characterized
Larger individuals may need higher doses to achieve equivalent therapeutic effects
US$ 20.82
US$ 22.60
US$ 21.11
US$ 22.89
US$ 27.17
US$ 25.15
US$ 28.36
US$ 20.92
US$ 29.56
